Sipuleucel-T (sip-T) overall survival (OS) and clinical outcomes by baseline (BL) prostate-specific antigen (PSA) quartiles in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): PROCEED registry.

A. Oliver  Sartor

Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Celgene; Constellation Pharmaceuticals; Dendreon; EMD Serono; Endocyte; Johnson & Johnson; Oncogenex; Pfizer; Sanofi

Research Funding - Bayer (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Johnson & Johnson (Inst); Merck; Sanofi (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals

Celestia S.  Higano

Employment - CTI (I)

Leadership - CTI (I)

Stock and Other Ownership Interests  - CTI (I)

Honoraria - Genentech

Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Dendreon; Endocyte; Ferring; Myriad Genetics; Orion; Tolmar

Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Medivation (Inst); Pfizer (Inst); Roche (Inst)

Travel, Accommodations, Expenses - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Dendreon; Endocyte; Ferring; Genentech; Menarini; Myriad Genetics; Orion; Pfizer

Matthew R.  Cooperberg

Honoraria - GenomeDx; Takeda

Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; MDxHealth; Myriad Pharmaceuticals

Research Funding - GenomeDx (Inst); Genomic Health (Inst); Myriad Pharmaceuticals (Inst)

Nicholas J.  Vogelzang

Employment - US Oncology

Stock and Other Ownership Interests  - Caris Life Sciences

Honoraria - Pfizer; UpToDate

Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals

Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi

Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)

Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology

Shaker R.  Dakhil

No Relationships to Disclose

Christopher Michael  Pieczonka

Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen

Speakers' Bureau - Astellas Pharma; Dendreon; Janssen

Research Funding - Astellas Pharma; Bayer; Dendreon; Janssen

Jeff  Vacirca

Employment - New York Cancer and Blood Specialists

Leadership - Odonate Therapeutics

Stock and Other Ownership Interests  - Flatiron Health; Odonate Therapeutics

Consulting or Advisory Role - AmerisourceBergen

Raoul S  Concepcion

Consulting or Advisory Role - Genomic Health; IntegraConnect

Speakers' Bureau - Amgen; Astellas Medivation; AstraZeneca; Dendreon; Janssen Oncology; Sanofi

Ronald F  Tutrone

Stock and Other Ownership Interests  - Novartis; Nymox; Sophiris Bio

Consulting or Advisory Role - 3D Biopsy; Medivation/Astellas; Pfizer

Speakers' Bureau - Dendreon; Medivation/Astellas

Research Funding - Advaxis (Inst); Allena Pharmaceuticals (Inst); Allergan (Inst); American Medical Systems (Inst); Bayer (Inst); Boston Scientific (Inst); Genentech/Roche (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Mundipharma (Inst); Neotract (Inst); Nymox (Inst); Sophiris Bio (Inst)

Luke T.  Nordquist

No Relationships to Disclose

Carl A  Olsson

Stock and Other Ownership Interests  - Egenix; Exelixis (I)

Research Funding - Advantagene (Inst); Dendreon (Inst); Medivation (Inst)

Other Relationship - American Urological Association

David F.  Penson

Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen

Research Funding - Astellas Pharma (Inst)

Ian  Schnadig

No Relationships to Disclose

James L.  Bailen

Honoraria - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi

Consulting or Advisory Role - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi

Speakers' Bureau - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi

Research Funding - Astellas Pharma (Inst); Bayer; Dendreon (Inst); Janssen (Inst); Medivation (Inst); Millennium

Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Valeant/Dendreon

Bryan  Mehlhaff

Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer

Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer

Speakers' Bureau - Abbvie; Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer

Research Funding - AstraZeneca; Bayer; Dendreon

Expert Testimony - United States government

Nancy N.  Chang

Employment - Dendreon

Stock and Other Ownership Interests  - Dendreon

Nadeem Anwar  Sheikh

Employment - Dendreon

Bruce  Brown

Employment - Dendreon

Andrew J.  Armstrong

Honoraria - Dendreon; Janssen Oncology; Sanofi

Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Pfizer; Sanofi

Speakers' Bureau - Bayer; Dendreon; Sanofi

Research Funding - Active Biotech (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)

Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)

Travel, Accommodations, Expenses - Bayer; Dendreon; Janssen Biotech; Medivation; Sanofi